Medical Condition News

RSS

TCGA examines ovarian serous adenocarcinoma tumors from 500 patients

An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature.

30 Jun 2011

STSI joins JAX consortium to develop targeted cancer therapies

The Scripps Translational Science Institute (STSI) of San Diego, Calif., has joined a national consortium of research institutions headed by The Jackson Laboratory (JAX) that is building a library of primary human tumors with the goal of developing highly targeted cancer therapies.

30 Jun 2011

Researchers develop way to uncover evolution of human cancer cells

A team of researchers led by scientists at the University of California, San Francisco has developed a way to uncover the evolution of human cancer cells, determining the order in which mutations emerge in them as they wend their way from a normal, healthy state into invasive, malignant masses.

30 Jun 2011

Prevalence rate of Parkinson's is higher than previously thought

Parkinson's Disease, brought to public awareness by figures such as Michael J. Fox, is not just difficult to diagnose. It's also difficult to accurately estimate how many people actually suffer from the disease. Current statistics come from small-scale studies, usually based on information from hospital clinics, and no registries or formal databases exist to track how many people have the disease.

30 Jun 2011

Obese patients more likely to suffer complication following elective plastic surgery

Obese patients are nearly 12 times more likely to suffer a complication following elective plastic surgery than their normal-weight counterparts, according to new research by Johns Hopkins scientists.

30 Jun 2011

Boston University, University of Utah Foundation and Allegro enter license agreement for molecular testing platform

Allegro Diagnostics today announced that the company has entered into an exclusive license agreement with Boston University and the University of Utah Foundation for intellectual property related to the company's molecular testing platform. This platform utilizes gene expression of normal epithelial cells in the respiratory tract to detect early signs of lung cancer.

30 Jun 2011

Hemova device can reduce risk of infection, clotting and vessel narrowing in dialysis patients

Johns Hopkins University graduate students have invented a device to reduce the risk of infection, clotting and narrowing of the blood vessels in patients who need blood-cleansing dialysis because of kidney failure.

30 Jun 2011

Protect your ears from loud noise of fireworks, trains, and concerts

The sounds of summer can be noisy. "Fireworks, trains, concerts and road construction can be harmful to your hearing. And once hearing is damaged, it cannot be repaired," said Jyoti Bhayani, certified audiologist at Gottlieb Memorial Hospital, part of Loyola University Health System.

30 Jun 2011

NLST: CT scans more effective in reducing lung cancer death rates

The National Lung Screening Trial (NLST) is the first scientific study that provides clear evidence that CT screening significantly reduces the death rate due to lung cancer.

30 Jun 2011

Modulating interaction between 'rotten eggs' gas and nitric oxide may treat heart failure

Research carried out by scientists from the Peninsula Medical School at the University of Exeter and the National University of Singapore has analysed the complex 'cross talk' between hydrogen sulphide and nitric oxide, both gasses that occur naturally in the body, and found that the interaction may offer potential strategies in the management of heart failure.

30 Jun 2011

Provectus presents additional data on PV-10 at two separate melanoma conferences

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that data and study design features on PV-10 for metastatic melanoma were presented at two separate conferences.

30 Jun 2011

Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility

Dendreon Corporation today announced that the U.S. Food and Drug Administration approved its Los Angeles cancer immunotherapy manufacturing facility, allowing the company to continue to increase the availability of PROVENGE across the U.S. to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.

30 Jun 2011

Gene overexpression linked with Alzheimer's disease and Down syndrome

Chronic stress has long been linked with neurodegeneration. Scientists at USC now think they may know why.

29 Jun 2011

Patients, scientists in different corners for cancer drug fight

The drug, Avastin, will be the subject of an unusual Food and Drug Administration hearing to revisit a panel vote last July that steered many doctors away from prescribing the drug for the treatment of breast cancer.

29 Jun 2011

Cayenne Medical introduces second generation device for treatment of traumatic meniscal tears

Cayenne Medical, Inc., a private sports medicine device company, announces the launch of CrossFix II Meniscal Repair System, its second generation device for treatment of traumatic meniscal tears.

29 Jun 2011

LVAD therapy an 'attractive option' for heart failure patients 70 years of age or older

Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart failure.

29 Jun 2011

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).

29 Jun 2011

GenSpera and University of Copenhagen collaborate on 'Sustainable Production of Thapsigargin using Light'

GenSpera, Inc. has entered into a cooperation agreement with the University of Copenhagen, in Copenhagen, Denmark, to collaborate on the "SPOTLight" (Sustainable Production of Thapsigargin using Light) project.

29 Jun 2011

Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET

Threshold Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET).

29 Jun 2011

ICU nurses doubt whether clinical neurological examination can establish brain death

More than half of Sweden's intensive care nurses doubt that a clinical neurological examination can establish that a patient is brain dead. Intensive care nurses also perceive that this uncertainty can affect relatives when the question of organ donation is raised, is reveiled in a thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden.

29 Jun 2011

Medical Condition News

TCGA examines ovarian serous adenocarcinoma tumors from 500 patients

STSI joins JAX consortium to develop targeted cancer therapies

Researchers develop way to uncover evolution of human cancer cells

Prevalence rate of Parkinson's is higher than previously thought

Obese patients more likely to suffer complication following elective plastic surgery

Boston University, University of Utah Foundation and Allegro enter license agreement for molecular testing platform

Hemova device can reduce risk of infection, clotting and vessel narrowing in dialysis patients

Protect your ears from loud noise of fireworks, trains, and concerts

NLST: CT scans more effective in reducing lung cancer death rates

Modulating interaction between 'rotten eggs' gas and nitric oxide may treat heart failure

Provectus presents additional data on PV-10 at two separate melanoma conferences

Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility

Gene overexpression linked with Alzheimer's disease and Down syndrome

Patients, scientists in different corners for cancer drug fight

Cayenne Medical introduces second generation device for treatment of traumatic meniscal tears

LVAD therapy an 'attractive option' for heart failure patients 70 years of age or older

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

GenSpera and University of Copenhagen collaborate on 'Sustainable Production of Thapsigargin using Light'

Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET

ICU nurses doubt whether clinical neurological examination can establish brain death

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News